STOCK TITAN

Bausch + Lomb to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Bausch + Lomb Corporation (BLCO) announced that Chairman and CEO Brent Saunders will participate in a fireside chat with investors at the 42nd Annual J.P. Morgan Healthcare Conference. Other company executives will also participate. A live webcast and audio archive of the event will be available on the Investor Relations page of the Bausch + Lomb website.
Positive
  • None.
Negative
  • None.

VAUGHAN, Ontario--(BUSINESS WIRE)-- Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that Chairman and CEO Brent Saunders will participate in a fireside chat with investors at the 42nd Annual J.P. Morgan Healthcare Conference on Jan. 8, 2024, at 11:15 a.m. PT (2:15 p.m. ET). Other company executives, including Chief Financial Officer Sam Eldessouky and Global Pharmaceuticals and International Consumer President Andrew Stewart, will also participate in the conference.

A live webcast and audio archive of the event will be available on the Investor Relations page of the Bausch + Lomb website: https://ir.bausch.com/investors/events-presentations.

About Bausch + Lomb

Bausch + Lomb is dedicated to protecting and enhancing the gift of sight for millions of people around the world – from the moment of birth through every phase of life. Its comprehensive portfolio of more than 400 products includes contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products and ophthalmic surgical devices and instruments. Founded in 1853, Bausch + Lomb has a significant global research and development, manufacturing and commercial footprint with approximately 13,000 employees and a presence in nearly 100 countries. Bausch + Lomb is headquartered in Vaughan, Ontario with corporate offices in Bridgewater, New Jersey. For more information, visit www.bausch.com and connect with us on X, LinkedIn, Facebook and Instagram.

© 2024 Bausch + Lomb.

Media:

T.J. Crawford

tj.crawford@bausch.com

(908) 705-2851

Investor:

George Gadkowski

george.gadkowski@bausch.com

(877) 354-3705 (toll free)

Source: Bausch + Lomb Corporation

The conference will take place on Jan. 8, 2024, at 11:15 a.m. PT (2:15 p.m. ET).

Chairman and CEO Brent Saunders, Chief Financial Officer Sam Eldessouky, and Global Pharmaceuticals and International Consumer President Andrew Stewart will participate.

The live webcast and audio archive will be available on the Investor Relations page of the Bausch + Lomb website: https://ir.bausch.com/investors/events-presentations.
Bausch + Lomb Corp

NYSE:BLCO

BLCO Rankings

BLCO Latest News

BLCO Stock Data

Ophthalmic Goods Manufacturing
Manufacturing

About BLCO

bausch and lomb corp is a renewables and environment company based out of calle laguna del marquesado nª 19, nave 16 edificio adriana 1ª planta, polígono industrial la resina (villaverde), madrid, community of madrid, spain.